TY - JOUR
T1 - The Use of Artificial Intelligence-based Technologies in Palliative Care
T2 - Advancing Patient Well-being at the End-of-life and Enhancing the Implementation of the Dying Patient Act
AU - Ben Shetrit, Shani
AU - Daghash, Jamal
AU - Sperling, Daniel
N1 - Publisher Copyright: © 2024 Israel Medical Association. All rights reserved.
PY - 2024/2
Y1 - 2024/2
N2 - In recent years, we have been experiencing a technological revolution, which signifies an ethical and societal transformation. Artificial intelligence (Al) based technologies have gradually permeated all aspects of life and solidified their position. Within this context, the emergence of these technologies offers new opportunities in the medical field, including palliative care, which is aimed at alleviating suffering and improving the quality of life for terminally ill patients and their families. In Israel, the Dying Patient Act of 2005 (the law), which promotes values such as the sanctity of life and individual autonomy, allows terminally ill patients to determine their preferred treatment, and withhold life-saving treatment under certain circumstances. The law represents a significant step toward improving care for terminally ill patients, reducing pain and suffering, and respecting the patient's wishes and worldviews in their final days. However, the practical implementation of the law has encountered numerous challenges, ranging from lack of familiarity among doctors and healthcare professionals and the requirement to determining life expectancy to fulfilling the law's purpose. These challenges are associated with ethical, cultural, and religious perspectives. In this article, we describe how Al-based technologies hold immense potential in applying the law and providing palliative care based on their predictive capabilities, prognostic accuracy, and optimization of treatment as well as communication between patients and healthcare providers. However, as an innovative, developing, and complex technology, it is crucial not to overlook the ethical, societal, and legal challenges inherent in implementing and using Al-based technologies in the context of palliative care.
AB - In recent years, we have been experiencing a technological revolution, which signifies an ethical and societal transformation. Artificial intelligence (Al) based technologies have gradually permeated all aspects of life and solidified their position. Within this context, the emergence of these technologies offers new opportunities in the medical field, including palliative care, which is aimed at alleviating suffering and improving the quality of life for terminally ill patients and their families. In Israel, the Dying Patient Act of 2005 (the law), which promotes values such as the sanctity of life and individual autonomy, allows terminally ill patients to determine their preferred treatment, and withhold life-saving treatment under certain circumstances. The law represents a significant step toward improving care for terminally ill patients, reducing pain and suffering, and respecting the patient's wishes and worldviews in their final days. However, the practical implementation of the law has encountered numerous challenges, ranging from lack of familiarity among doctors and healthcare professionals and the requirement to determining life expectancy to fulfilling the law's purpose. These challenges are associated with ethical, cultural, and religious perspectives. In this article, we describe how Al-based technologies hold immense potential in applying the law and providing palliative care based on their predictive capabilities, prognostic accuracy, and optimization of treatment as well as communication between patients and healthcare providers. However, as an innovative, developing, and complex technology, it is crucial not to overlook the ethical, societal, and legal challenges inherent in implementing and using Al-based technologies in the context of palliative care.
KW - artificial intelligence (Al)
KW - Dying Patient Act
KW - palliative care
UR - http://www.scopus.com/inward/record.url?scp=85186626065&partnerID=8YFLogxK
M3 - Review article
C2 - 38420987
SN - 1565-1088
VL - 26
SP - 126
EP - 129
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 2
ER -